 |
Health Technology Assessment in Osteoporosis |
M. Hiligsmann, J.A. Kanis, J. Compston, C. Cooper, B. Flamion, P; Bergmann, J.-J. Body, S. Boonen, O. Bruyère, J.-P. Devogelaer, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster
|
 |
Incidence and socioeconomic burden of hip fractures in Italy: extension study
2003-2005 |
P. Piscitelli, M.L. Brandi, U. Tarantino, A. Baggiani, A. Distante, M. Muratore, V. Grattagliano, A. Migliore, M. Granata, G. Guglielmi, R. Gimigliano, G. Iolascon
|
 |
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis |
B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. A. Kanis.
|
 |
Validation of the IOF quality of life questionnaire for patients with wrist fracture |
P. Lips, K. Jameson, M. L. Bianchi, S. Goemaere, S. Boonen, J. Reeve, J. Stepan, O. Johnell, N. M. van Schoor, E. Dennison, J. A. Kanis, C. Cooper, Working Group for Quality of Life of the International Osteoporosis Foundation.
|
 |
FRAX® and its applications in health economics - Cost-effectiveness and intervention thresholds
using bazedoxifene in a Swedish setting as an example |
O. Ström, F. Borgström, M. Kleman, E. McCloskey, A. Odén, H. Johansson, J.A. Kanis.
|
 |
Osteoporosis: burden, health care provision and opportunities in the EU |
O. Ström, F. Borgström, J. A. Kanis, J. Compston, C. Cooper, E. V. McCloskey, B. Jönsson.
|
 |
An evaluation of the NICE guidance for the prevention of osteoporotic fragility
fractures in postmenopausal women |
J. A. Kanis, E. V. McCloskey, B. Jonsson, A. Cooper, O. Ström, F. Borgström
|
|
The cost-effectiveness of alendronate in the management of osteoporosis |
J. A. Kanis, J. Adams, F. Borgström, C. Cooper, Bengt Jönsson, D. Preedy, P. Selby, J. Compston.
|
 |
Reply to Letter to the Editor: Modelling cost-effectiveness in osteoporosis |
J. A. Kanis, J. Adams, F. Borgström, C. Cooper, Bengt Jönsson, D. Preedy, P. Selby, J. Compston.
|
 |
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish
setting |
F. Borgström, B. Jönsson, O. Ström, J. A. Kanis |
 |
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international
perspective |
F. Borgström . Å. Carlsson . H. Sintonen . S. Boonen . P. Haentjens . R. Burge . O. Johnell . B. Jönsson . J. A. Kanis
|
 |
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for
the treatment of osteoporosis |
F. Borgström; O. Johnell, J. A. Kanis, B. Jönsson, C. Rehnberg
|
|
Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on
the Women's Health Initiative randomized controlled trial |
N. Zethraeus, F. Borgström, B. Jönsson, J. A. Kanis |
|
Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the
UK - Results based on the Women's Health Initiative randomised controlled trial |
I. Lekander, F. Borgström, O. Ström, N. Zethraeus, J. A. Kanis
|
 |
Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK |
I. Lekander, F. Borgström, O. Ström, N. Zethraeus, J. A. Kanis |
 |
Glucocorticoid-induced osteoporosis: a systematic review and cost - utility analysis |
J. A. Kanis, JE. Brazier, MD. Stevenson, E.V. McCloskey, S. Davis, M. Lloyd-Jones
|
 |
Description of an individual patient methodology for calculating the cost-effectiveness of
treatments for osteoporosis in women |
MD. Stevenson, JE Brazier, NW Calvert, M. Lloyd-Jones, JE Oakley, J. A. Kanis
|
 |
Incorporating adherence into health economic modelling of osteoporosis |
O. Ström, F. Borgström, J. A. Kanis, B. Jönsson |
 |
Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and
a reference model |
N. Zethraeus, F. Borgström, O. Ström, J. A. Kanis, B. Jönsson
|
 |
The Cost-Effectiveness of Bisphosphonates in Postmenopausal Women Based on Individual Long-Term
Fracture Risks |
T.-P. van Staa, J. A. Kanis, P. Geusens, A. Boonen, H. G. M. Leufkens, C. Cooper
|
 |
Utility Values Associated with Osteoporotic Fracture: A Systematic Review of the Literature
|
M. Hiligsmann, O. Ethgen, F. Richy, J.-Y. Reginster |
 |
Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications |
M. Hiligsmann, V. Rabenda, H.-J. Gathon, O. Ethgen, J.-Y. Reginster
|
 |
Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of
Treatments in Osteoporosis |
M. Hiligsmann, O. Ethgen, O. Bruyere, F. Richy, H.-J. Gathon, J.-Y. Reginster
|
 |
An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification
of Patients with Osteoporosis |
M. Hiligsmann, O. Ethgen, O. Bruyere, J.-Y. Reginster |
 |
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal
osteoporotic women aged over 75 years |
M. Hiligsmann, O. Bruyere, J.-Y. Reginster |
 |
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic
women |
M. Hiligsmann, O. Bruyere, J.-Y. Reginster |
 |
The need for economic evaluation in osteoarthritis |
O. Bruyere, J.-Y. Reginster |
 |
Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards
economic analysis |
O. Bruyere, S. Scholtissen, A. Neuprez, M. Hiligsmann, A. Toukouki, J.-Y. Reginster
|
 |
The risk and burden of vertebral fractures in Sweden |
J.A. Kanis, O. Johnell, A. Oden, F. Borgstrom, N. Zethraeus, C. De Laet, B. Jonsson
|
 |
The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic
patients |
M. Hiligsmann, V. Rabenda, O. Bruyere, J.-Y. Reginster |
 |
Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication
Adherence |
M. Hiligsmann, H.-J. Gathon, O. Bruyere, O. Ethgen, V. Rabenda, J.-Y. Reginster
|
 |
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
|
F. Borgström, O. Ström, J. Coelho, H. Johansson, A. Oden, E. V. McCloskey, J. A. Kanis
|
 |
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
|
F. Borgström, O. Ström, J. Coelho, H. Johansson, A. Oden, E. V. McCloskey, J. A. Kanis
|